News

Why do some patients benefit more from PARP inhibitors than others?
PARP inhibitors in recent years have significantly improved care for ovarian cancer. However, not all patients benefit and some develop resistance over time.
Stress does not cause cancer, concludes new meta-analysis
‘Our brains are wired to look for reasons,’ said one of the study authors. ‘And when we can’t pinpoint them, we feel a sense of helplessness.’

Pharmacist wins mental disorder case tied to chemo exposure, child’s autism

A B.C. workplace compensation tribunal said lack of proof did not undermine a reasonable belief that led to a mental disorder.
'The Pharmacists Are In' podcast chats with key Ontario pharmacy stakeholders at PharmacyU Toronto

Amid the throng of guests, podcast hosts and community pharmacists John Papastergiou and Ajit Johal chatted with Hitesh Pandya, chair of the Ontario Pharmacists Association and Justin Bates, CEO of Ontario Pharmacists Association.
Celebrating 15 years of Pharmacy U Toronto

Canada's largest in-person event for community pharmacists turned 15 this month with a new format showcasing both targeted education and product innovation.
Shortages of drugs for people with arthritis causes stress, long-term behaviour changes and more: new report

Study from the Canadian Arthritis Patient Alliance highlights systemic challenges impacting Canadians with arthritis.
Health spending and other highlights from P.E.I.’s latest budget

Healthcare spending is projected to rise by 14.2% to $1.4 billion.
Some babies requiring surgery in Regina now to go to Saskatoon: health authority

The rules came into effect earlier this month, and Dr. Mike Kelly, the head of surgery at the Saskatchewan Health Authority, says it applies to newborns, premature infants and medically complex babies.
The 2026 Medical Post Awards are now open for nominations

The annual awards, adjudicated by panels of physician judges, support Canadian physician voices, contributions to community and practice innovation. Nominations close May 22.
Could a cholesterol drug prevent first heart attacks in diabetes patients?

Study finds evolocumab lowers first heart attacks and strokes even in patients without known atherosclerosis.